Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol for pediatric traumatic brain injury
IRCT20161103030683N2Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of propranolol in traumatic brain injury (TBI) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Mortality rate, PICU length of stay and 2 more. Started Oct 2023; status: completed.
02
Drugs
propranolol
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20161103030683N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20161103030683N2.